secukinumab,baricitinib,guselkumab,anifrolumab,methotrexate,apremilast
janssen,novartis,astrazeneca,amgen,incyte,eli lilly
['methotrexate', 'anifro', 'baricitinib', 'psoriatic arthritis', 'secukinumab', 'spondylitis', 'apremilast', ' psa', 'psoriasis', 'lupus', 'guselkumab']
it s been an eventful few years for in rheumatology. what an interesting ride #eular2023 
Rheumatologist and clinical pharmacologist, world traveller pretences on the upswing, sometimes journal podcast host. All opinions my own